0% found this document useful (0 votes)
53 views38 pages

5 Tetanus

- Tetanus is caused by a neurotoxin produced by Clostridium tetani bacteria. It causes muscle spasms and rigidity. - It occurs worldwide but is more common in developing countries. In 2015 there were approximately 57,000 tetanus deaths globally, with 20,000 in neonates. - Neonatal tetanus results from infection of the umbilical stump in newborns of mothers without adequate immunization. It presents as difficulty feeding and muscle spasms in infants.

Uploaded by

Dawit g/kidan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
53 views38 pages

5 Tetanus

- Tetanus is caused by a neurotoxin produced by Clostridium tetani bacteria. It causes muscle spasms and rigidity. - It occurs worldwide but is more common in developing countries. In 2015 there were approximately 57,000 tetanus deaths globally, with 20,000 in neonates. - Neonatal tetanus results from infection of the umbilical stump in newborns of mothers without adequate immunization. It presents as difficulty feeding and muscle spasms in infants.

Uploaded by

Dawit g/kidan
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PPT, PDF, TXT or read online on Scribd
You are on page 1/ 38

Tetanus

6/6/2021 1
• A non-communicable infectious disease
• An acute, spastic paralytic illness caused by a
neurotoxin produced by Clostridium tetani
• C. tetani is not a tissue invasive organism and instead
causes illness through the toxin, tetanospasmin ,
more commonly referred to as tetanus toxin

6/6/2021 2
Epidemiology
• Occurs worldwide and is endemic in many
developing countries
• Approximately 57,000 deaths were caused by
tetanus globally in 2015
• Of these, approximately 20,000 deaths occurred in
neonates and 37,000 in older children and adults

6/6/2021 3
• Most mortality from neonatal (or umbilical) tetanus
occurs in South Asia and Sub-Saharan Africa
• Mortality in adults is largely caused by maternal
tetanus, which results from postpartum, postabortal,
or postsurgical wound infection with C. tetani.
• Most non-neonatal cases of tetanus are associated
with a traumatic injury, often a penetrating wound
inflicted by a dirty object such as a nail, splinter,
fragment of glass, or unsterile injection

6/6/2021 4
• The disease may also occur in association with
animal bites, abscesses , ear and other body
piercing, chronic skin ulceration, burns,
compound fractures, gangrene, intestinal
surgery
• What are the risk factors for neonatal
tetanus?

6/6/2021 5
Pathogenesis
• Tetanus spores access to damaged human tissue
• After inoculation, C. tetani transforms into a
vegetative rod-shaped bacterium and produces the
metalloprotease tetanus toxin
• Reach the spinal cord & brainstem via retrograde
axonal transport within the motor neuron
• Toxin is secreted and enters adjacent inhibitory
interneurons, where it blocks neurotransmission by
its cleaving action on the membrane proteins
involved in neuroexocytosis
6/6/2021 6
• The net effect is inactivation of inhibitory
neurotransmission that normally modulates anterior
horn cells and muscle contraction
• This loss of inhibition of anterior horn cells and
autonomic neurons results in increased muscle tone,
painful spasms, and widespread autonomic
instability
• Lack of neural control of adrenal release of
catecholamines induced by tetanus toxin produces a
hyper-sympathetic state that manifests as sweating,
tachycardia, & hypertension
6/6/2021 7
Clinical Manifestations
• Tetanus can present in one of four clinical
patterns
1. Generalized
2. Local
3. Cephalic
4. Neonatal

6/6/2021 8
• Incubation period of tetanus is 8 days but ranges
from 3 to 21 days; shorter in neonatal tetanus
• Inoculation of spores in body locations distant from
the CNS (eg, the hands or feet) results in a longer
incubation period

6/6/2021 9
Generalized tetanus
• Most common and severe clinical form of tetanus
• Trismus (lockjaw) in more than 50% of cases
• Autonomic over activity that may manifest in the
early phases as irritability, restlessness, sweating,
and tachycardia----in later phases of illness, profuse
sweating, cardiac arrhythmias, labile hypertension or
hypotension, and fever
• Tonic contraction of skeletal muscles & intermittent
intense muscular spasms

6/6/2021 10
• Pts with tetanus have no impairment of
consciousness or awareness, both the tonic
contractions and spasms are intensely painful.
• Tetanic spasms may be triggered by loud noises or
other sensory stimuli such as physical contact or light

6/6/2021 11
• Tonic and periodic spastic muscular contractions are
responsible for most of the classic clinical findings of
tetanus:
 stiff neck
 opisthotonus
 risus sardonicus (sardonic smile),
 board-like rigid abdomen, periods of apnea
and/or upper airway obstruction due to vise-like
contraction of the thoracic muscles and/or glottal
or pharyngeal muscle contraction, respectively,
 dysphagia
6/6/2021 12
Lockjaw: spasm of facial muscles.

Risus sardonicus: A sardonic smile (facial muscle spasms)

6/6/2021 13
Opisthotonus

6/6/2021 14
• During generalized tetanic spasms, pts characteristically
clench their fists, arch their back, and flex and abduct their
arms while extending their legs, often becoming apneic
during these dramatic postures

6/6/2021 15
Local tetanus
• Rarely, tetanus presents with tonic & spastic
muscle contractions in one extremity or body
region
• Often evolves into generalized tetanus
• Dx can be difficult

6/6/2021 16
Cephalic tetanus
• In pts with injuries to the head or neck
• Involving initially only cranial nerves
• Like other forms of local tetanus, pts with cephalic tetanus
often subsequently develop generalized tetanus
• The facial nerve is most commonly involved

6/6/2021 17
Neonatal tetanus
• The infantile form of generalized tetanus, typically
manifests within 3-12 days of birth
• It presents as progressive difficulty in feeding
(sucking and swallowing), associated hunger, and
crying
• Occurs as a result of the failure to use aseptic
techniques in managing the umbilical stump in
offspring of mothers who are poorly immunized

6/6/2021 18
Clinical manifestation neonatal
tetanus
• Diagnosis is clinical as confirming the infection is
difficult
• The newborn usually exhibits:
 irritability
 poor feeding, difficulty in opening the mouth
 rigidity
 facial grimacing
 severe spasms with stimulation

6/6/2021 19
• The umbilical stump, which is typically the
portal of entry for the microorganism, may
retain remnants of dirt, dung, clotted blood,
or serum, or it may appear relatively benign
• Without good supportive care, case fatality
rates can exceed 90%.

6/6/2021 20
Assignment
• Write the Case definition for neonatal
tetanus!

6/6/2021 21
Severity of illness
• May vary from case to case, depending upon the amount of
tetanus toxin that reaches CNS
• The severity is related to the incubation period of the illness
& the interval from the onset of symptoms to the appearance
of spasms, the longer the interval, the milder
• Illness may be milder in pts with preexisting but
nonprotective levels of antitetanus antibodies

6/6/2021 22
Duration of illness
• Tetanus toxin-induced effects are long lasting
because recovery requires the growth of new
axonal nerve terminals
• The usual duration of clinical tetanus is four to
six weeks.

6/6/2021 23
dx
• Usually obvious and can generally be made based upon
typical clinical findings outlined above
• The typical setting is an unimmunized pt(and/or mother) who
was injured or born within the preceding 2 wk, who presents
with trismus, dysphagia, generalized muscle rigidity and
spasm, and a clear sensorium
• Results of routine lab studies are usually normal
• An assay for antitoxin levels is not readily available, although
a serum antitoxin level of ≥0.01 IU/mL is generally considered
protective and makes the dx of tetanus less likely

6/6/2021 24
ddx
• Drug-induced dystonias such as those due to
phenothiazines
• Trismus may result from parapharyngeal,
retropharyngeal, or dental abscesses or rarely from
acute encephalitis involving the brainstem

6/6/2021 25
Complications
• Laryngospasm
• Hyperactivity of the ANS leading to HTN, abnormal heart rate,
or both
• Fractures of the spine or long bones as a result of sustained
contractions and convulsions
• Nosocomial infections
• Pulmonary embolism
• Aspiration pneumonia
• Death

6/6/2021 26
Goals of Rx
• Halting the toxin production
• Neutralization of the unbound toxin
• Airway management
• Control of muscle spasms
• Mgt of dysautonomia
• General supportive management

6/6/2021 27
Halting toxin production
• Wound Mgt-----surgery
 surgical wound excision and debridement are
often needed to remove the foreign body or
devitalized tissue that created the anaerobic
growth conditions necessary for replication
• Antimicrobial therapy: Oral (IV) metronidazole (30
mg/kg/day, given at 6 hr intervals; maximum dose, 4
g/day) decreases the number of vegetative forms of
C. tetani and is currently considered the antibiotic of
choice
6/6/2021 28
• Parenteral penicillin G (100,000 U/kg/day,
administered at 4-6 hr intervals, with a daily
maximum 12 million U) is an alternative Rx
• Antimicrobial therapy for a total duration of 7-
10 days is recommended.

6/6/2021 29
Neutralization of unbound toxin
• Since tetanus toxin is irreversibly bound to tissues,
only unbound toxin is available for neutralization
• Human tetanus immune globulin (TIG) should be
readily available and is the preparation of choice
• A dose of 3000 to 6000 units IM should be given as
soon as the dx of tetanus is considered, with part of
the dose infiltrated around the wound

6/6/2021 30
• In parts of the world where it is available, another
alternative may be equine derived TAT
• A dose of 1,500-3,000 U is recommended and
should be administered after appropriate testing for
sensitivity and desensitization,

6/6/2021 31
Control of muscle spasms
• All pts with generalized tetanus should receive
muscle relaxants
• Diazepam has been used most frequently
• The initial dose of 0.1- 0.2 mg/kg every 3-6 hr
intravenously is subsequently titrated to control the
tetanic spasms
• Magnesium sulfate, other benzodiazepines
(midazolam), chlorpromazine, dantrolene, and
baclofen are also used

6/6/2021 32
• Favorable survival rates in generalized tetanus have
been described with the use of neuromuscular
blocking agents such as vecuronium and
pancuronium, which produce a general flaccid
paralysis that is then managed by mechanical
ventilation.

6/6/2021 33
Mgt of autonomic dysfunction
• Several drugs have been used to produce adrenergic blockade
and suppress autonomic hyperactivity;
• Only Rx with magnesium sulfate has been studied in a
randomized clinical trial in tetanus
• Beta blockade--Labetalol(0.25 to 1.0 mg/min) has frequently
been administered because of its dual alpha- and beta-
blocking properties
• Morphine sulfate (0.5 to 1.0 mg/kg per hour by continuous
intravenous infusion) is commonly used to control autonomic
dysfunction as well as to induce sedation.

6/6/2021 34
Airway Mgt and other supportive
measures
• Oxygen should be available
• Endotracheal intubation
• Early tracheostomy
• Prophylactic subcutaneous heparin may be of
value, but it must be balanced with the risk of
hemorrhage

6/6/2021 35
Factors Associated with a Poor
Prognosis in Tetanus
• Age >70 years
• Incubation period <7 days
• Short time from first symptom to admission
• Puerperal, IV, postsurgery, burn entry site
• Period of onset <48 h
• Heart rate >140 beats/min
• Systolic blood pressure >140 mmHg
• Severe disease or spasms
• Temperature >38.5°Cb
6/6/2021 36
Factors Associated with a Poor
Prognosis in Tetanus---neonatal
• Younger age
• Premature birth
• Incubation period <6 days
• Delay in hospital admission
• Grass used to cut cord
• Low birth weight
• Fever on admission

6/6/2021 37
Prevention
• Easily preventable disease
• A serum Ab titer of ≥0.01 U/mL is considered protective
• Active immunization should begin in early infancy(6-10-
14wks) and with boosters at 4-6 yr and 11-12 yr of age, and at
10 yr intervals thereafter throughout adult life with tetanus
toxoid
• Immunization of women with tetanus toxoid prevents
neonatal tetanus

6/6/2021 38

You might also like